Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

SELL
$242.49 - $301.46 $456,851 - $567,950
-1,884 Reduced 4.03%
44,889 $11 Million
Q2 2022

Jul 29, 2022

BUY
$224.73 - $338.64 $844,310 - $1.27 Million
3,757 Added 8.73%
46,773 $11.6 Million
Q1 2022

May 13, 2022

BUY
$277.25 - $366.29 $260,060 - $343,580
938 Added 2.23%
43,016 $14.2 Million
Q4 2021

Feb 09, 2022

BUY
$300.63 - $371.35 $1.56 Million - $1.92 Million
5,180 Added 14.04%
42,078 $15.2 Million
Q3 2021

Nov 02, 2021

BUY
$310.19 - $376.2 $35,361 - $42,886
114 Added 0.31%
36,898 $12 Million
Q2 2021

Aug 03, 2021

BUY
$262.71 - $351.17 $442,929 - $592,072
1,686 Added 4.8%
36,784 $11.5 Million
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $209,007 - $259,600
731 Added 2.13%
35,098 $11.2 Million
Q4 2020

Feb 12, 2021

BUY
$251.88 - $324.2 $25,188 - $32,420
100 Added 0.29%
34,367 $11 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $557,400 - $692,328
2,184 Added 6.81%
34,267 $9.49 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $212,524 - $386,406
1,503 Added 4.91%
32,083 $7.75 Million
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $476,361 - $715,436
3,650 Added 13.55%
30,580 $4.44 Million
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $535,759 - $751,765
3,363 Added 14.27%
26,930 $4.59 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $72,818 - $115,601
414 Added 1.79%
23,567 $4.19 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $304,665 - $345,917
1,214 Added 5.53%
23,153 $6.03 Million
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $12.7 Million - $16.7 Million
-46,012 Reduced 67.71%
21,939 $6.27 Million
Q4 2018

Feb 13, 2019

BUY
$281.08 - $444.25 $85,167 - $134,607
303 Added 0.45%
67,951 $22 Million
Q3 2018

Nov 14, 2018

BUY
$354.53 - $449.75 $209,881 - $266,252
592 Added 0.88%
67,648 $30.4 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $18.6 Million - $29.9 Million
67,056 New
67,056 $27.4 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.